Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             131 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Brief Overview of the Preclinical and Clinical Radiobiology of Microbeam Radiotherapy Fukunaga, H.

11 p. 705-712
artikel
2 Adaptive Radiotherapy Enabled by MRI Guidance Hunt, A.
2018
11 p. 711-719
artikel
3 Advancing Roles of Healthcare Professionals in Palliative Radiotherapy Fitzpatrick, C.

11 p. 753-757
artikel
4 Anal Cancer: Developing an Intensity-modulated Radiotherapy Solution for ACT2 Fractionation Muirhead, R.
2014
11 p. 720-721
2 p.
artikel
5 An Overview of the Role of Radiotherapy in the Treatment of Small Cell Lung Cancer – A Mainstay of Treatment or a Modality in Decline? Merie, R.

11 p. 741-752
artikel
6 An Overview of Uncommon Cutaneous Malignancies, Including Skin Appendageal (Adnexal) Tumours and Sarcomas Craig, P.J.
2019
11 p. 769-778
artikel
7 Are Cyclin-dependent Kinase 4/6 Inhibitors Needed for all Oestrogen Receptor-positive Metastatic Breast Cancers? Johnston, S.R.D.
2017
11 p. 703-706
4 p.
artikel
8 Assessment and Optimisation of Lung Cancer Patients for Treatment with Curative Intent Harris, C.
2016
11 p. 682-694
13 p.
artikel
9 Assessment of the Implementation of Lung Cancer Consensus Statements From the Royal College of Radiologists in 2021; Progress and Barriers McAleese, J.

11 p. e463-e471
artikel
10 Association of Computed Tomography Radiomics Signature with Progression-free Survival in Neuroblastoma Patients Wang, H.

11 p. e639-e647
artikel
11 Audit of Molecular Mechanisms of Primary and Secondary Resistance to Various Generations of Tyrosine Kinase Inhibitors in Known Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Cancer Patients in a Tertiary Centre Suryavanshi, M.

11 p. e451-e462
artikel
12 Best Practice Recommendations for the Retention of Radiotherapy Records Lockhart, E.
2017
11 p. e195-e202
nvt p.
artikel
13 Bone Health and Pelvic Radiotherapy Higham, C.E.
2015
11 p. 668-678
11 p.
artikel
14 Cancer of Unknown Primary Presenting with Liver Metastasis: A Cost, Time to Treatment and Outcome Analysis Saif Ur Rehman, S.
2013
11 p. 684-685
2 p.
artikel
15 Can Rational Combination of Ultra-high Dose Rate FLASH Radiotherapy with Immunotherapy Provide a Novel Approach to Cancer Treatment? Zhang, Y.

11 p. 713-722
artikel
16 Cardiac Side-effects From Breast Cancer Radiotherapy Taylor, C.W.
2015
11 p. 621-629
9 p.
artikel
17 Challenges to Treating Older Glioblastoma Patients: the Influence of Clinical and Tumour Characteristics on Survival Outcomes Lorimer, C.F.
2017
11 p. 739-747
9 p.
artikel
18 Combined Radiotherapy and New Systemic Therapies – Have We Moved Beyond Palliation? Fife, K.

11 p. 758-765
artikel
19 Combining External Beam Radiation and Radionuclide Therapies: Rationale, Radiobiology, Results and Roadblocks Abbott, E.M.

11 p. 735-743
artikel
20 Comparison of four-week accelerated hypofractionated chemo intensity-modulated radiotherapy (IMRT) versus less accelerated schedules in oropharyngeal carcinoma Boon, Ian S.
2017
11 p. e204-
1 p.
artikel
21 Complex Clinical Decision-Making Process of Re-Irradiation Armstrong, S.

11 p. 688-703
artikel
22 Could Clinical Oncology Training Address Manpower Issues in Low and Middle Income Countries? Woolf, D.K.
2014
11 p. 730-
1 p.
artikel
23 Current Concepts in the Surgical Management of Non-melanoma Skin Cancers Kosutic, D.
2019
11 p. 738-748
artikel
24 Current Role of Radiotherapy in Non-melanoma Skin Cancer Veness, M.J.
2019
11 p. 749-758
artikel
25 Cutaneous Lymphomas Specht, L.
2019
11 p. 797-807
artikel
26 Delivering Functional Imaging on the MRI-Linac: Current Challenges and Potential Solutions Datta, A.
2018
11 p. 702-710
artikel
27 Dual-Centre Harmonised Multimodal Positron Emission Tomography/Computed Tomography Image Radiomic Features and Machine Learning Algorithms for Non-small Cell Lung Cancer Histopathological Subtype Phenotype Decoding Khodabakhshi, Z.

11 p. 713-725
artikel
28 Early Diagnosis and Lung Cancer Screening Balata, H.

11 p. 708-715
artikel
29 Electrochemotherapy and Ablative Therapies in Non-melanoma Skin Cancer O'Donoghue, N.
2019
11 p. e1-e9
artikel
30 Estimating the Value of Surgical Clips for Target Volume Delineation in External Beam Partial Breast Radiotherapy Ippolito, E.
2014
11 p. 677-683
7 p.
artikel
31 Evolving Role of Systemic Therapies in Non-melanoma Skin Cancer Conforti, C.
2019
11 p. 759-768
artikel
32 Feasibility of Hippocampal Avoidance Radiotherapy for Glioblastoma Thippu Jayaprakash, K.
2017
11 p. 748-752
5 p.
artikel
33 Febrile Neutropaenia and Chemotherapy Discontinuation in Women Aged 70 Years or Older Receiving Adjuvant Chemotherapy for Early Breast Cancer Adjogatse, D.
2014
11 p. 692-696
5 p.
artikel
34 Follow-up Care for Survivors of Prostate Cancer – Clinical Management: a Program in Evidence-Based Care Systematic Review and Clinical Practice Guideline Loblaw, A.
2017
11 p. 711-717
7 p.
artikel
35 Functional Image-guided Radiotherapy Planning for Normal Lung Avoidance Ireland, R.H.
2016
11 p. 695-707
13 p.
artikel
36 Haemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction of the TNM Staging System in Nasopharyngeal Carcinoma: Development and Validation in 3237 Patients from a Single Institution Chang, H.
2013
11 p. 639-646
8 p.
artikel
37 Health Economic and Health Service Issues of Palliative Radiotherapy Barton, M.

11 p. 775-780
artikel
38 Helping Patients to Help Themselves after Breast Cancer Treatment Fenlon, D.R.
2015
11 p. 640-646
7 p.
artikel
39 Hypoalbuminaemia is an Independent Predictor of Poor Outcome in Metastatic Ewing's Sarcoma Family of Tumours: A Single Institutional Experience of 150 Cases Treated with Uniform Chemotherapy Protocol Biswas, B.
2014
11 p. 722-729
8 p.
artikel
40 IBC RCR Meetings 2013
11 p. IBC-
1 p.
artikel
41 Impact of Positron Emission Tomography and Endoscopic Ultrasound Length of Disease Difference on Treatment Planning in Patients with Oesophageal Cancer Foley, K.G.
2017
11 p. 760-766
7 p.
artikel
42 Implementing Genomic Testing for Lung Cancer Into Routine Clinical Practice – The Welsh Experience Cox, S.

11 p. 716-723
artikel
43 Initial outcome and toxicity of stereotactic ablative body radiotherapy (SABR) for early stage lung cancer in a single UK centre Boon, Ian S.
2017
11 p. e204-e205
nvt p.
artikel
44 Introducing the Cancer Research UK Advanced Radiotherapy Technologies Network (ART-NET) Harrington, K.
2017
11 p. 707-710
4 p.
artikel
45 Is a 14-day Pathway From Decision to Treat to Radiotherapy for Head and Neck Cancer Patients Feasible in the National Health Service? The Torbay Experience 5 Years On Cope, V.

11 p. 756-758
artikel
46 Is It Me Or Is It Hot In Here? A Plea For More Research Into Hot Flushes Morgan, A.
2013
11 p. 681-683
3 p.
artikel
47 Is There Still a Role for Radiation Therapy in the Management of Benign Disease? Fionda, B.

11 p. 698-700
artikel
48 Leveraging Radiobiology for Arrhythmia Management: A New Treatment Paradigm? Zhang, D.M.

11 p. 723-734
artikel
49 Longstanding Challenges in Lung Cancer: Are We Meeting Them? Snee, M.
2016
11 p. 669-671
3 p.
artikel
50 Looking Forward Ajithkumar, T.V.

11 p. 691
artikel
51 Lung Cancer in 2022 and Beyond! Thippu Jayaprakash, K.

11 p. 695-697
artikel
52 Lung Cancer in the Non-smoker: A Patient View Focused on the Hopes and Challenges Facing the Non-smoker Population Rawlinson, J.

11 p. 698-700
artikel
53 Machine Learning Study of SNPs in Noncoding Regions to Predict Non-small Cell Lung Cancer Susceptibility Huang, Y.

11 p. 701-712
artikel
54 Magnetic Resonance-guided Radiotherapy — Can We Justify More Expensive Technology? Tree, A.C.
2018
11 p. 677-679
artikel
55 Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): A 4.5-Year Clinical Experience Henke, L.E.
2018
11 p. 720-727
artikel
56 Magnetic Resonance Imaging-based Tumour Perfusion Parameters are Biomarkers Predicting Response after Radiation to Brain Metastases Jakubovic, R.
2014
11 p. 704-712
9 p.
artikel
57 Magnetic Resonance Imaging only Workflow for Radiotherapy Simulation and Planning in Prostate Cancer Kerkmeijer, L.G.W.
2018
11 p. 692-701
artikel
58 Management of Non-melanoma Skin Cancer in Transplant Recipients Collins, L.
2019
11 p. 779-788
artikel
59 Merkel Cell Carcinoma – Current Controversies and Future Directions Steven, N.
2019
11 p. 789-796
artikel
60 Mismatch Repair as a Prognostic Marker for Adjuvant Therapy in Colorectal Cancer – How Soon is Now? O'Leary, B.
2013
11 p. 625-629
5 p.
artikel
61 Model Selection for the Preclinical Development of New Drug–Radiotherapy Combinations Singh, J.

11 p. 694-704
artikel
62 More Effort is Needed to Improve the Practice of Radiotherapy in Africa Zaghloul, M.S.
2014
11 p. 730-731
2 p.
artikel
63 MRI-Linear Accelerator Radiotherapy Systems Liney, G.P.
2018
11 p. 686-691
artikel
64 Neurocognitive Effects Following Cranial Irradiation for Brain Metastases Pinkham, M.B.
2015
11 p. 630-639
10 p.
artikel
65 Non-coplanar VMAT treatment for glioblastoma patients; initial experience from Aberdeen Royal Infirmary Tough, Fay
2017
11 p. e204-
1 p.
artikel
66 Non-Melanoma Skin Cancer – An Underestimated Global Health Threat? Rembielak, A.
2019
11 p. 735-737
artikel
67 Novel Radiobiology is an Essential Pillar for the Future of Radiation Oncology Sharma, R.A.

11 p. 681-682
artikel
68 OncoFlash – Research Updates in a Flash! (Nov 2023) Lorimer, C.

11 p. 695-697
artikel
69 OncoFlash - Research Updates in a Flash! (November edition) Crockett, C.

11 p. 692-694
artikel
70 Palliative Radiation Therapy in Older Adults With Cancer: Age-Related Considerations O'Donovan, A.

11 p. 766-774
artikel
71 Parotid Dosimetric Changes Correlate to Weight Loss during Radical but Not Adjuvant Head and Neck Radiotherapy: An Exploratory Analysis Chatterjee, S.
2013
11 p. 685-686
2 p.
artikel
72 Patient-reported Outcome Measures in Radiotherapy: Clinical Advances and Research Opportunities in Measurement for Survivorship Faithfull, S.
2015
11 p. 679-685
7 p.
artikel
73 Persistent Dysphagia after Head and Neck Radiotherapy: A Common and Under-reported Complication with Significant Effect on Non-cancer-related Mortality Szczesniak, M.M.
2014
11 p. 697-703
7 p.
artikel
74 Poor Outcomes after Whole Brain Radiotherapy in Patients with Brain Metastases: Results from an International Multicentre Cohort Study Windsor, A.A.
2013
11 p. 674-680
7 p.
artikel
75 Predictive Factors for Local Control in Primary and Metastatic Lung Tumours after Four to Five Fraction Stereotactic Ablative Body Radiotherapy: A Single Institution's Comprehensive Experience Thibault, I.
2014
11 p. 713-719
7 p.
artikel
76 Predictors of Asymptomatic Radiation-induced Abdominal Atherosclerosis Cella, L.
2017
11 p. e186-e194
nvt p.
artikel
77 Prehabilitation and Rehabilitation for Patients with Lung Cancer: A Review of Where we are Today Burnett, C.

11 p. 724-732
artikel
78 Prevention and Management of Radiation-induced Late Gastrointestinal Toxicity Teo, M.T.W.
2015
11 p. 656-667
12 p.
artikel
79 Prostascore: A Simplified Tool for Predicting Outcomes among Patients with Treatment-naive Advanced Prostate Cancer Abdel-Rahman, O.
2017
11 p. 732-738
7 p.
artikel
80 Radical Radiotherapy for Locally Advanced Non-small Cell Lung Cancer: When Should Concurrent Chemoradiotherapy Not Be Used? De Ruysscher, D.
2016
11 p. 708-711
4 p.
artikel
81 Radiosensitising Effects of Metformin Added to Concomitant Chemoradiotherapy with Cisplatin in Cervical Cancer Beduk Esen, C.S.

11 p. 744-755
artikel
82 Radiotherapy and Immunotherapy Combinations in Non-small Cell Lung Cancer: A Promising Future? Hanna, G.G.
2016
11 p. 726-731
6 p.
artikel
83 Radiotherapy in Craniopharyngiomas Iannalfi, A.
2013
11 p. 654-667
14 p.
artikel
84 Rapid Access Palliative Radiotherapy Programmes Dennis, K.

11 p. 704-712
artikel
85 RCR Meetings
11 p. I
artikel
86 RCR Meetings 2014
11 p. I-
1 p.
artikel
87 RCR Meetings 2018
11 p. I
artikel
88 RCR Meetings 2017
11 p. I-
1 p.
artikel
89 RCR Meetings 2015
11 p. I-
1 p.
artikel
90 RCR Meetings 2016
11 p. I-
1 p.
artikel
91 RCR Meetings 2019
11 p. I-II
artikel
92 RCR Meetings
11 p. I
artikel
93 RCR Meetings
11 p. I
artikel
94 Reducing time to palliative radiotherapy Higgins, Emma
2017
11 p. e205-
1 p.
artikel
95 Repurposing Proton Beam Therapy through Novel Insights into Tumour Radioresistance Chua, K.L.M.

11 p. e469-e481
artikel
96 Repurposing Radiation Therapy for Immuno-oncology Tang, J.

11 p. 683-693
artikel
97 Response assessments on MRI after two cycles of bevacizumab (Bev) and neurological status in recurrent glioblastoma Dixit, Sanjay
2017
11 p. e205-
1 p.
artikel
98 Review of Conventional and High Dose Rate Brain Radiation (FLASH): Neurobehavioural, Neurocognitive and Assessment Issues in Rodent Models Vorhees, C.V.

11 p. e482-e491
artikel
99 Routine Clinical Data Predict Survival after Palliative Radiotherapy: An Opportunity to Improve End of Life Care Williams, M.
2013
11 p. 668-673
6 p.
artikel
100 Sexual Difficulties after Pelvic Radiotherapy: Improving Clinical Management White, I.D.
2015
11 p. 647-655
9 p.
artikel
101 Small cell cancer of the oesophagus – a network series Martin, Amy
2017
11 p. e205-
1 p.
artikel
102 Spine and Non-spine Bone Metastases – Current Controversies and Future Direction Challapalli, A.

11 p. 728-744
artikel
103 Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage Lung Cancer – A Done Deal? Gulstene, S.

11 p. 733-740
artikel
104 Stereotactic Body Radiotherapy versus Low Dose Rate Brachytherapy for Localised Prostate Cancer: a Cost–Utility Analysis Helou, J.
2017
11 p. 718-731
14 p.
artikel
105 Stereotactic Radiosurgery and Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease Chen, H.

11 p. 713-727
artikel
106 Supportive Care: An Indispensable Component of Modern Oncology Berman, R.

11 p. 781-788
artikel
107 Surgical and Radiotherapeutic Management of Malignant Extradural Spinal Cord Compression Loblaw, A.

11 p. 745-752
artikel
108 Surveillance and Deregulated Pathways in Oral Merkel Cell Carcinoma Mukesh Kumar, D.J.

11 p. 758-759
artikel
109 Survivorship Issues in Radiation Oncology Jena, R.
2015
11 p. 619-620
2 p.
artikel
110 Ten-Year Outcomes of Stereotactic Body Radiotherapy for Oligometastatic Breast Cancer: Does Synchronous Oligometastatic Breast Cancer Benefit? Nagpal, S.K.

11 p. 736-743
artikel
111 The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer Harrow, S.
2016
11 p. 720-725
6 p.
artikel
112 The Challenges of Using MRI During Radiotherapy McWilliam, A.
2018
11 p. 680-685
artikel
113 The Current Role of Radiotherapy in the Treatment of Small Cell Lung Cancer Woolf, D.K.
2016
11 p. 712-719
8 p.
artikel
114 The Effect of Image Guidance on Dose Distributions in Breast Boost Radiotherapy Donovan, E.M.
2014
11 p. 671-676
6 p.
artikel
115 The Efficacy of Induction Chemotherapy with Docetaxel, Cisplatin and 5-fluorouracil Combined with Cisplatin Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Matched Pair Analysis Teo, M.
2013
11 p. 647-653
7 p.
artikel
116 The Evolving Practice of Palliative Radiotherapy Rembielak, A.

11 p. 685-687
artikel
117 The Management of Oligometastases in Non-small Cell Lung Cancer – is Stereotactic Ablative Radiotherapy now Standard of Care? Ratnakumaran, R.

11 p. 753-760
artikel
118 The National Lung Cancer Audit: The Impact of COVID-19 Conibear, J.

11 p. 701-707
artikel
119 The Potential Value of MRI in External-Beam Radiotherapy for Cervical Cancer Cree, A.
2018
11 p. 737-750
artikel
120 The Prognostic Significance of the Biomarker p16 in Oropharyngeal Squamous Cell Carcinoma Oguejiofor, K.K.
2013
11 p. 630-638
9 p.
artikel
121 Therapeutic Modification of Hypoxia Horsman, M.R.

11 p. e492-e509
artikel
122 The Role of Magnetic Resonance Imaging in Brachytherapy Tharmalingam, H.
2018
11 p. 728-736
artikel
123 The Role of Positron Emission Tomography/Computed Tomography Imaging in Head and Neck Cancer after Radical Chemoradiotherapy: a Single Institution Experience Nelissen, C.
2017
11 p. 753-759
7 p.
artikel
124 The Use of Palliative Radiotherapy in the Treatment of Lung Cancer King, J.

11 p. 761-770
artikel
125 Treatment Variation of Sequential versus Concurrent Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer Patients in the Netherlands and Belgium Walraven, I.
2017
11 p. e177-e185
nvt p.
artikel
126 Trifluridine/tipiracil (Lonsurf®) use in metastatic colorectal cancer: efficacy outcome and toxicity in a single UK centre Boon, Ian S.
2017
11 p. e204-
1 p.
artikel
127 Use of Radiomics Models in Preoperative Grading of Cerebral Gliomas and Comparison with Three-dimensional Arterial Spin Labelling Zhu, F.-Y.

11 p. 726-735
artikel
128 Utility of Prognostic Markers in Second-line Treatment of Metastatic Urothelial Cancer Raby, S.E.M.
2017
11 p. e206-
1 p.
artikel
129 Validation of a Nomogram in the Prediction of Local Recurrence Risks after Conserving Surgery for Asian Women with Ductal Carcinoma in Situ of the Breast Wang, F.
2014
11 p. 684-691
8 p.
artikel
130 What is the Optimum Screening Strategy for the Early Detection of Lung Cancer Baldwin, D.R.
2016
11 p. 672-681
10 p.
artikel
131 What's Current and What's New in Mesothelioma? Leal, J.L.

11 p. 771-780
artikel
                             131 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland